Mount Sinai Hospital
Critical Care Outcomes in Hematologic Malignancy and Stem Cell Transplant
Patients with leukemia (blood cancer) may become critically ill because of their disease or complications of treatment; and may require intensive care unit (ICU) admission. Approximately 1/3 of patients die in ICU, and survivors may be left with significant longterm disability. Our study will evaluate long-term outcomes of patients who develop critical illness and identify factors we can modify to improve their outcome.